GI
DYN icon

GAMMA Investing’s Dyne Therapeutics DYN Stock Holding History

GAMMA Investing’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.6K Buy
1,153
+104
+10% +$1.93K ﹤0.01% 2704
2026
Q1 		$19K Buy
1,049
+208
+25% +$3.59K ﹤0.01% 2739
2025
Q4 		$16.4K Buy
841
+192
+30% +$3.64K ﹤0.01% 2716
2025
Q3 		$8.21K Buy
649
+137
+27% +$1.56K ﹤0.01% 2975
2025
Q2 		$4.87K Buy
512
+261
+104% +$2.87K ﹤0.01% 3131
2025
Q1 		$2.63K Sell
251
-29
-10% -$415 ﹤0.01% 3328
2024
Q4 		$6.6K Buy
280
+43
+18% +$1.27K ﹤0.01% 2794
2024
Q3 		$8.51K Buy
237
+41
+21% +$1.63K ﹤0.01% 2525
2024
Q2 		$6.92K Buy
196
+18
+10% +$523 ﹤0.01% 2424
2024
Q1 		$5.05K Buy
178
+16
+10% +$362 ﹤0.01% 2406
2023
Q4 		$3.47K Buy
+162
New +$1.58K ﹤0.01% 2388

Other funds holding DYN

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
AP
Aspect Partners Fairfax, Virginia $268M AUM 22.57% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

GAMMA Investing's DYN Position: Q2 2026 in Review

GAMMA Investing increased its Dyne Therapeutics (DYN) stake by 9.9% in Q2 2026, buying an estimated $1.93K and bringing the position to 1,153 shares worth $25.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2704.

GAMMA Investing first reported a position in DYN in Q4 2023 and has held it in 11 quarters since. 12 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • GAMMA Investing held 1,153 shares of Dyne Therapeutics worth $25.6K as of Q2 2026.
  • GAMMA Investing bought 104 Dyne Therapeutics shares in Q2 2026, an estimated $1.93K.
  • Dyne Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2704 holding.
  • GAMMA Investing first reported a position in Dyne Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 12 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.